Yuji Matsuzawa Selected Research

Yuji Matsuzawa Research Topics

Disease

55	Obesity 01/2021 - 04/2002
36	Insulin Resistance 01/2021 - 02/2002
31	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 02/2002
28	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2002
26	Coronary Artery Disease (Coronary Atherosclerosis) 06/2022 - 02/2002
23	Atherosclerosis 10/2016 - 09/2002
21	Hypertension (High Blood Pressure) 02/2021 - 11/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2002
17	Hypercholesterolemia 10/2015 - 01/2002
15	Hypoadiponectinemia 05/2012 - 09/2002
14	Vascular Diseases (Vascular Disease) 04/2008 - 04/2002
13	Coronary Disease (Coronary Heart Disease) 02/2021 - 11/2002
13	Neoplasms (Cancer) 01/2010 - 04/2002
12	Diabetes Mellitus 01/2010 - 11/2002
11	Body Weight (Weight, Body) 08/2010 - 10/2002
10	Inflammation (Inflammations) 11/2016 - 06/2003
9	Abdominal Obesity 03/2013 - 01/2003
8	Dyslipidemias (Dyslipidemia) 02/2021 - 01/2003
6	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2021 - 01/2004
6	Hyperglycemia 10/2015 - 01/2002
6	Hyperuricemia 06/2011 - 06/2011
5	Hypertriglyceridemia 01/2020 - 07/2003
5	Cholesteryl Ester Transfer Protein Deficiency 10/2016 - 07/2002
5	Gout 06/2011 - 06/2011
4	Xanthomatosis (Xanthoma) 02/2021 - 08/2015
4	Stroke (Strokes) 06/2020 - 11/2005
4	Mason-Type Diabetes 12/2005 - 01/2002
4	Glucose Intolerance 01/2005 - 06/2002
4	Lipodystrophy 06/2004 - 05/2002
3	Liver Diseases (Liver Disease) 01/2020 - 10/2007
3	Cushing Syndrome 01/2016 - 10/2003
3	Non-alcoholic Fatty Liver Disease 10/2015 - 10/2007
3	Fatty Liver 10/2015 - 02/2002
3	Drug-Related Side Effects and Adverse Reactions 06/2011 - 06/2011
3	Hyperlipidemias (Hyperlipidemia) 10/2006 - 06/2003
3	Vascular Remodeling 02/2006 - 06/2002
3	Overweight 12/2005 - 11/2002
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2005 - 01/2002
3	Hyperinsulinism (Hyperinsulinemia) 11/2002 - 10/2002
2	Chronic Renal Insufficiency 06/2020 - 05/2003
2	Kidney Diseases (Kidney Disease) 06/2020 - 06/2012
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 05/2019
2	Necrosis 07/2019 - 12/2005
2	Tangier Disease 10/2018 - 08/2002
2	Weight Gain 10/2015 - 10/2002
2	Gastritis 08/2011 - 12/2003

Drug/Important Bio-Agent (IBA)

95	AdiponectinIBA 01/2021 - 01/2002
28	LipidsIBA 02/2021 - 10/2002
26	AdipokinesIBA 01/2021 - 04/2002
25	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2002
22	HDL CholesterolIBA 02/2021 - 07/2002
19	CholesterolIBA 11/2018 - 07/2002
19	Proteins (Proteins, Gene)FDA Link 08/2012 - 04/2002
17	Insulin (Novolin)FDA Link 10/2020 - 06/2002
17	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2002
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2020 - 01/2002
11	oxidized low density lipoproteinIBA 02/2021 - 10/2002
9	LDL CholesterolIBA 02/2021 - 01/2004
9	Simvastatin (Zocor)FDA LinkGeneric 03/2010 - 12/2002
8	Messenger RNA (mRNA)IBA 04/2013 - 04/2002
8	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2007 - 04/2002
7	Probucol (Lorelco)FDA Link 06/2022 - 12/2008
7	Eicosapentaenoic AcidIBA 01/2012 - 07/2008
7	C-Reactive ProteinIBA 08/2011 - 02/2003
7	Epidermal Growth Factor (EGF)IBA 01/2007 - 01/2002
6	HDL LipoproteinsIBA 02/2021 - 08/2002
6	Pharmaceutical PreparationsIBA 01/2020 - 11/2003
6	Heparin (Liquaemin)FDA LinkGeneric 01/2007 - 04/2002
6	Nicotinamide PhosphoribosyltransferaseIBA 01/2007 - 01/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 07/2002
6	Hormones (Hormone)IBA 05/2005 - 05/2002
5	Cholesterol Ester Transfer ProteinsIBA 10/2016 - 07/2002
5	Febuxostat FDA Link 06/2011 - 06/2011
5	Xanthine OxidaseIBA 06/2011 - 06/2011
5	Uric Acid (Urate)IBA 06/2011 - 11/2002
5	Plasminogen InactivatorsIBA 01/2007 - 05/2004
5	ApolipoproteinsIBA 04/2005 - 02/2002
5	Lipoproteins (Lipoprotein)IBA 03/2005 - 05/2003
4	LDL Lipoproteins (beta Lipoproteins)IBA 02/2021 - 01/2004
4	Allopurinol (Remid)FDA LinkGeneric 06/2011 - 06/2011
4	purineIBA 06/2011 - 06/2011
4	LeptinIBA 01/2011 - 05/2002
3	AntioxidantsIBA 02/2021 - 12/2008
3	Fibric Acids (Fibrates)IBA 01/2020 - 08/2003
3	lipoprotein cholesterolIBA 06/2012 - 05/2005
3	Hemoglobins (Hemoglobin)IBA 06/2011 - 01/2008
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2007 - 04/2004
3	Plasminogen Activator Inhibitor 1IBA 12/2005 - 05/2004
3	PPAR gammaIBA 05/2005 - 02/2002
3	Hepatocyte Nuclear FactorsIBA 04/2005 - 01/2002
3	Interleukin-6 (Interleukin 6)IBA 12/2003 - 01/2003
2	CreatinineIBA 01/2020 - 08/2010
2	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2020 - 05/2019
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2013 - 08/2003
2	AcidsIBA 12/2011 - 12/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2011 - 12/2009
2	CytokinesIBA 08/2011 - 01/2003

Therapy/Procedure

16	Therapeutics 02/2021 - 12/2002
7	Secondary Prevention 02/2021 - 12/2002
3	Highly Active Antiretroviral Therapy (HAART) 06/2004 - 04/2003